We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Gene Linked to Sporadic Form of Breast Cancer

By Biotechdaily staff writers
Posted on 17 Oct 2002
Researchers have identified a tumor suppressor gene called DBC2 (for "deleted in breast cancer”) that is missing or inactive in as many as 60% of breast cancers. More...
This finding was reported in the October 7, 2002, online edition of the Proceedings of the National Academy of Sciences.

DBC2 was cloned from a homozygously deleted region on human chromosome 8p21. It is one of the few tumor suppressor genes to be clearly associated with sporadic breast cancer, which accounts for more than 90% of breast cancers. Heritable forms of the disease make up less than 10% of breast cancers.

The investigators, from the Cold Spring Harbor Laboratory (NY, USA) and the University of Washington (Seattle, USA; ), showed that production of the DBC2 protein in breast cancer cells killed cancer cells or prevented them from growing. The same group from the University of Washington discovered the first gene linked to hereditary breast cancer, BRCA1, in 1990, while the same Cold Spring Harbor group identified a tumor suppressor gene called PTEN in 1997.




Related Links:
Cold Spring Harbor Laboratory
University of Washington

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Prefilled Tubes
Prefilled 5.0ml Tubes
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.